09
Nov

Byetta Side Effects: FDA Issues New Warnings On Diabetes Drug

Byetta aka Exenatide: Reports from diabetics of kidney problems & renal failure prompt new warnings from U.S. Food and Drug Administration on diabetes drug.
The U.S. Food and Drug Administration (FDA) has approved new language to be included on the drug label of popular diabetes medication Byetta, also known as exenatide. The new language will include [...]

06
May

FDA extended time to review saxagliptin for treatment of diabetes

Endocrine Today, NJ
The Food and Drug Administration has extended the date of the Prescription Drug User Fee Act from April 30, 2009 to July 30, 2009, stating that additional time is needed to complete the review of saxagliptin for the treatment of Type Two Diabetes.

Topics: prescription, diabetes, Saxagliptin, food and drug administration, type two, News, cells, [...]

06
May

Januvia linked to pancreatitis risk

The Diabetes drug Januvia may cause abnormalities in the pancreas, an animal clinical study has found.

Topics: News, Januvia, health, diabetes, diabetes drug, risk, pancreas, Drug, study

Related Articles

Some diabetes drugs linked to eye disorder
FDA: Diabetes drug Onglyza appears safe
Drug Deals Tie Money to How Patients Do
Diabetes Drug Class Linked To Vision Threatening Complication

06
May

FDA delays decision on diabetes treatment Onglyza

BusinessWeek
Drugmakers Bristol-Myers Squibb Co. and AstraZeneca PLC said Thursday federal regulators need more time to review their application for the Diabetes treatment Onglyza. The Food and Drug Administration has extended its deadline for making a decision on …

Topics: food and drug administration, FDA, treatment, fitness, News, cells, Saxagliptin, diabetes, Drug, AstraZeneca

Related Articles

FDA extended time to [...]